LifeMine Therapeutics Company
LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Founded Date:
2016-01-01
Last Funding Type:
Series C
Headquarters:
Cambridge, Massachusetts, United States
Investors Number:
14.0
Technology:
['BioTech & HealthTech']
Employee Number:
51-100
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-23
Funding Status:
Late Stage Venture
Total Funding:
295000000.0